This may in part explain the lack of predisposition to developing cancer in patients with neurofibromatosis 2, though the explanation is not complete, since there remains considerable overlap between neurofibromatosis 2 and cancer-related NF2 aberrations (Figure 2)[11, 12]. Here, NF2 is linked to NF2-related schwannomatosis.